As the coming Asian Games spotlight athletic performance, CUHK researchers are pursuing a broader goal: preserving mobility throughout life. Through CNRM’s international collaboration, the University is advancing scalable, allogeneic mesenchymal stromal cell therapy for knee osteoarthritis. The work links global manufacturing expertise with CUHK research to bring regenerative medicine closer to clinical application and wider patient benefit for people worldwide.

Imagine that some of the most aggressive cancers can be cured and patients no longer have to face a bleak destiny. For years, cancer patients had little hope for a cure despite all the excruciating surgery, chemotherapy and radiation. But now, those who were once hopeless are experiencing miraculous recoveries, thanks to the advent of cell and gene therapy. CUHK’s Advanced Therapy Products Good Manufacturing Practice Centre promises to help researchers speed up clinical trials and deliver breakthrough treatments, opening a new era of hope and possibility.